Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Zai Lab Ltd (ZLAB) AI Forecast

Our AI analyzed Zai Lab Ltd. Create a free account to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$ZLAB Neutral Signal Full forecast available
Sign Up Free

Zai Lab Ltd (ZLAB) Stock Forecast 2025

Zai Lab Ltd (ZLAB) AI Stock Price Forecast & Investment Analysis

Zai Lab Ltd Stock Price Chart and Technical Analysis

Loading chart...

Zai Lab Ltd (ZLAB) - Comprehensive Stock Analysis & Investment Research

Deep dive into Zai Lab Ltd's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 3, 2026, 1:55 a.m. (UTC)

Zai Lab Ltd Investment Summary

When evaluating whether Zai Lab Ltd (ZLAB) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Zai Lab Ltd (ZLAB) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $2 billion, the company is a mid-cap stock that typically offers a balance between growth potential and established business operations.

Financial Performance Analysis

Our comprehensive financial analysis covers Zai Lab Ltd's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Zai Lab Ltd along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Zai Lab Ltd is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Zai Lab Ltd

Sign Up Free
Corporate Identity

Zai Lab Ltd (Stock Symbol: ZLAB) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Zai Lab Ltd's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Zai Lab Ltd...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Zai Lab Ltd...

Unlock Full Company Profile

Get complete details about Zai Lab Ltd

Sign Up Free
Revenue & Growth Analysis

Zai Lab Ltd generates annual revenues of $460 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Zai Lab Ltd...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Zai Lab Ltd...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Zai Lab Ltd...

Unlock Financial Analysis

Get complete financial metrics for Zai Lab Ltd

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Zai Lab Ltd's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Zai Lab Ltd strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a mid-cap company, it occupies an attractive position balancing growth potential with established operations. Mid-caps often represent the 'sweet spot' for investors seeking companies that have proven their business models but still have meaningful runway for expansion. These companies are large enough to have competitive advantages but nimble enough to adapt quickly to market changes.

Industry Competitive Landscape

Zai Lab Ltd competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Margin & Pricing Power Analysis

The company maintains a 63.0% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.

Operating margin of -124.3% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Financial Strength & Leverage

Zai Lab Ltd (ZLAB) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Zai Lab Ltd stock analysis.

Deep dive into Zai Lab Ltd's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Zai Lab Ltd stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Zai Lab Ltd: With a P/E ratio of -95.17, the market sees the stock as potentially undervalued.

P/E Ratio -95.17x
P/B Ratio 3.01x
Market Cap $2.15B
EPS $-0.20
Book Value/Share $6.39
Revenue/Share $4.11
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Zai Lab Ltd converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Zai Lab Ltd:

Gross Margin 63.0%
Operating Margin -124.3%
Net Margin -75.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Zai Lab Ltd's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Zai Lab Ltd:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Zai Lab Ltd's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Zai Lab Ltd:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Zai Lab Ltd uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Zai Lab Ltd:

Understanding Financial Statement Data

What these metrics mean: Key figures from Zai Lab Ltd's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Zai Lab Ltd: With annual revenue of $460M, Zai Lab Ltd demonstrates solid business size.

Income Statement
Total Revenue $460M
R&D Expense $264M
Cost of Goods Sold $81M
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 112M
Growth Metrics (YoY)
EPS Growth -0.9%

Latest Zai Lab Ltd Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Zai Lab Ltd (ZLAB) stock price and investment outlook.

More news available

Sign up free to read all 12 news articles and stay updated on market developments.

Sign Up Free to Read More

Zai Lab Ltd Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Zai Lab Ltd against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aardvark Therapeutics, Inc. AARD ██% $119M x 1.0x
Abbvie Inc. ABBV ██% $414.41B 98.1x 291.8x
Abcellera Biologics Inc. ABCL ██% $1.15B -5.3x 1.2x
Abeona Therapeutics Inc. ABEO ██% $265M 3.2x 1.6x
Abbott Laboratories ABT ██% $198.68B 30.5x 3.8x
Arbutus Biopharma Corp ABUS ██% $896M -8.3x 11.6x
Abvc Biopharma, Inc. ABVC ██% $36M -0.3x 3.0x
Abivax S.A. ABVX ██% $8.94B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.88B 9.9x 3.2x
Adicet Bio, Inc. ACET ██% $70M -0.4x 0.6x
Aclaris Therapeutics, Inc. ACRS ██% $330M -4.5x 3.2x
Acrivon Therapeutics, Inc. ACRV ██% $48M -2.8x 0.4x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $8M x 10.3x
Acurx Pharmaceuticals, Inc. ACXP ██% $4M -0.8x 1.1x
Adagene Inc. ADAG ██% $140M x 3.7x
Adc Therapeutics Sa ADCT ██% $471M -9.2x -1.3x
Adial Pharmaceuticals, Inc. ADIL ██% $3M -0.1x 0.6x
Aditxt, Inc. ADTX ██% $850K 0.0x 0.1x
Addex Therapeutics Ltd. ADXN ██% $9M x x
Aeon Biopharma, Inc. AEON ██% $27M 5.9x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.71B 3.7x 1.4x
Ainos, Inc. AIMD ██% $11M -0.4x 1.1x
Akebia Therapeutics, Inc. AKBA ██% $334M -5.4x 10.3x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $11M -2.0x 0.5x
Aldeyra Therapeutics, Inc. ALDX ██% $338M -5.1x 7.6x
Alkermes Plc. ALKS ██% $5.01B 20.7x 2.8x
Allarity Therapeutics, Inc. ALLR ██% $16M -0.2x 1.3x
Alumis Inc. ALMS ██% $3.71B x 9.6x
Alnylam Pharmaceuticals, Inc. ALNY ██% $43.03B 137.2x 54.5x
Altimmune, Inc. ALT ██% $521M -5.7x 2.8x
Alx Oncology Holdings Inc ALXO ██% $278M -0.4x 6.2x
Alzamend Neuro, Inc. ALZN ██% $8M -0.1x 1.8x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.68B -1.5x 5.1x
Amphastar Pharmaceuticals, Inc. AMPH ██% $959M 9.8x 2.2x
Amarin Corp Plc\Uk AMRN ██% $290M -4.5x 0.6x
Amneal Pharmaceuticals, Inc. AMRX ██% $4.32B 59.9x 218.1x
Anaptysbio, Inc ANAB ██% $1.51B -2.5x 44.5x
Anebulo Pharmaceuticals, Inc. ANEB ██% $15M -4.3x 1.9x
Ani Pharmaceuticals Inc ANIP ██% $1.69B 21.6x 3.1x
Anixa Biosciences Inc ANIX ██% $98M -15.0x 6.5x
Annexon, Inc. ANNX ██% $820M -4.1x 5.1x
Alto Neuroscience, Inc. ANRO ██% $641M x 5.8x
An2 Therapeutics, Inc. ANTX ██% $29M x 0.5x
Annovis Bio, Inc. ANVS ██% $71M -1.0x 5.4x
Apollomics Inc. APLM ██% $43M x x
Apellis Pharmaceuticals, Inc. APLS ██% $2.71B 121.2x 7.3x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $6M -1.2x 0.6x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $17M x 2.1x
Aptevo Therapeutics Inc. APVO ██% $11M -0.1x 0.6x
Aquestive Therapeutics, Inc. AQST ██% $500M -10.7x 49.6x
Arcturus Therapeutics Holdings Inc. ARCT ██% $226M -7.0x 1.0x
Ardelyx, Inc. ARDX ██% $1.58B -21.3x 9.5x
Arcutis Biotherapeutics, Inc. ARQT ██% $3.05B -6.6x 16.1x
Artelo Biosciences, Inc. ARTL ██% $3M -0.7x 4.0x
Arvinas, Inc. ARVN ██% $983M -4.8x 2.3x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $8.84B 43.7x 15.6x
Aspire Biopharma Holdings, Inc. ASBP ██% $7M x x
Assembly Biosciences, Inc. ASMB ██% $469M -1.5x 2.6x
Ascendis Pharma A/S ASND ██% $15.00B x x
Assertio Holdings, Inc. ASRT ██% $76M -0.2x 0.7x
Atai Beckley N.V. ATAI ██% $1.34B -4.4x 8.4x
Alterity Therapeutics Ltd ATHE ██% $63M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $36M -4.1x 2.6x
Atossa Therapeutics, Inc. ATOS ██% $37M -6.2x 0.7x
Avenue Therapeutics, Inc. ATXI ██% $780K -9.5x 0.2x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $1.88B 6.6x 3.2x
Arrivent Biopharma, Inc. AVBP ██% $951M x 3.1x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $366M -1.5x 1.2x
Avalo Therapeutics, Inc. AVTX ██% $333M -0.1x 3.6x
Axim Biotechnologies, Inc. AXIM ██% $2M x 0.4x
Axsome Therapeutics, Inc. AXSM ██% $8.47B -19.9x 95.9x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $2M -0.2x 0.9x
Bridgebio Pharma, Inc. BBIO ██% $12.76B -11.6x -5.4x
Bicara Therapeutics Inc. BCAX ██% $961M x 2.4x
Briacell Therapeutics Corp. BCTX ██% $28M -1.7x 2.8x
Bicycle Therapeutics Plc BCYC ██% $397M -6.0x 0.6x
Bioadaptives, Inc. BDPT ██% $220K x 18.3x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $6M -2.9x 3.1x
Biofrontera Inc. BFRI ██% $11M -0.1x 23.0x
Bausch Health Companies Inc. BHC ██% $2.26B 14.4x 4.2x
Bioharvest Sciences Inc. BHST ██% $108M x 81.3x
Biohaven Ltd. BHVN ██% $1.57B -4.6x 30.1x
Bioage Labs, Inc. BIOA ██% $906M x 3.3x
Bio Essence Corp BIOE ██% $3M x x
Biovie Inc. BIVI ██% $10M -0.6x 0.5x
Bioxytran, Inc BIXT ██% $4M x 7.8x
Biolinerx Ltd. BLRX ██% $13M x x
Belite Bio, Inc BLTE ██% $6.98B x 77.2x
Biomea Fusion, Inc. BMEA ██% $93M -1.6x 5.9x
Biomarin Pharmaceutical Inc BMRN ██% $11.82B 22.7x 2.0x
Bristol Myers Squibb Co BMY ██% $125.29B 17.8x 6.8x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $373M -0.6x 2.0x
Boundless Bio, Inc. BOLD ██% $26M -15.1x 0.2x
Bolt Biotherapeutics, Inc. BOLT ██% $10M -0.3x 0.3x
Bio-Path Holdings, Inc. BPTH ██% $550K 0.0x 3.6x
Bioquest Corp BQST ██% $15M x 3.0x
Barinthus Biotherapeutics Plc. BRNS ██% $24M -0.6x 0.3x
Bespoke Extracts, Inc. BSPK ██% $3M x 172.9x
Bioxcel Therapeutics, Inc. BTAI ██% $33M -0.1x 5.7x
Beyondspring Inc. BYSI ██% $55M 48.5x 1.0x
Calcimedica, Inc. CALC ██% $7M 0.4x 1.2x
Camp4 Therapeutics Corp CAMP ██% $233M -0.1x 4.0x
Can-Fite Biopharma Ltd. CANF ██% $6M x 1.5x
Capricor Therapeutics, Inc. CAPR ██% $1.52B x 18.1x
Carisma Therapeutics Inc. CARM ██% $2M 0.2x 0.0x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $617M -2.8x 2.6x
Crescent Biopharma, Inc. CBIO ██% $333M -6.5x 1.6x
Cdt Equity Inc. CDT ██% $2M -0.7x 0.4x
Cingulate Inc. CING ██% $47M -0.6x 13.4x
Cell Source, Inc. CLCS ██% $42M x 3666.2x
Clene Inc. CLNN ██% $58M -7.3x 13.7x
Cellectar Biosciences, Inc. CLRB ██% $14M x 1.7x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Climb Bio, Inc. CLYM ██% $488M -1.4x 2.8x
Chemomab Therapeutics Ltd. CMMB ██% $11M 10.9x 1.2x
Clearmind Medicine Inc. CMND ██% $2M x x
Compass Pathways Plc CMPS ██% $783M 0.0x 20.8x
Cnbx Pharmaceuticals Inc. CNBX ██% $90K x 0.1x
Cns Pharmaceuticals, Inc. CNSP ██% $2M 0.0x 0.2x
Centessa Pharmaceuticals Plc CNTA ██% $3.61B -11.0x 12.0x
Connect Biopharma Holdings Ltd CNTB ██% $138M x 2.5x
Context Therapeutics Inc. CNTX ██% $223M -1.5x 3.1x
Cocrystal Pharma, Inc. COCP ██% $14M -1.0x 1.8x
Cogent Biosciences, Inc. COGT ██% $6.25B -3.7x 9.8x
Collegium Pharmaceutical, Inc COLL ██% $1.32B 21.0x 4.4x
Corcept Therapeutics Inc CORT ██% $3.78B 38.0x 5.8x
Coya Therapeutics, Inc. COYA ██% $104M -6.8x 3.8x
China Pharma Holdings, Inc. CPHI ██% $3M -0.2x 0.3x
Cumberland Pharmaceuticals Inc CPIX ██% $74M -4.5x 2.8x
Cannapharmarx, Inc. CPMD ██% $3M x 1.9x
Catalyst Pharmaceuticals, Inc. CPRX ██% $3.05B 14.2x 3.2x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $150M -2.0x 1.6x
Cormedix Inc. CRMD ██% $559M 3.4x 1.5x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.93B -15.9x 4.0x
Cervomed Inc. CRVO ██% $37M -0.7x 1.4x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.53B -13.7x 21.3x
Cytomx Therapeutics, Inc. CTMX ██% $910M 32.5x 8.5x
Contineum Therapeutics, Inc. CTNM ██% $560M x 3.1x
Citius Oncology, Inc. CTOR ██% $95M 3.9x 1.6x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Citius Pharmaceuticals, Inc. CTXR ██% $17M -5.3x 0.2x
Cue Biopharma, Inc. CUE ██% $26M -1.2x 1.9x
Cadrenal Therapeutics, Inc. CVKD ██% $20M -11.1x 7.3x
Cv Sciences, Inc. CVSI ██% $12M x 8.1x
Cyclerion Therapeutics, Inc. CYCN ██% $5M -5.2x 0.5x
Cytodyn Inc. CYDY ██% $316M 86.7x 114.3x
Cryoport, Inc. CYRX ██% $422M 5.9x 0.8x
Cytokinetics Inc CYTK ██% $7.61B -9.4x 70.1x
Dare Bioscience, Inc. DARE ██% $24M 2.9x 8.5x
Day One Biopharmaceuticals, Inc. DAWN ██% $1.09B -8.9x 2.5x
Journey Medical Corp DERM ██% $289M 24.1x 11.2x
Diamedica Therapeutics Inc. DMAC ██% $414M -4.2x 8.0x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $2.37B -3.2x 4.3x
Dermata Therapeutics, Inc. DRMA ██% $4M -0.2x 1.0x
Bright Minds Biosciences Inc. DRUG ██% $885M x x
Design Therapeutics, Inc. DSGN ██% $595M -7.6x 3.0x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $91M -2.9x 12.6x
Dyne Therapeutics, Inc. DYN ██% $2.56B -7.8x 3.7x
Emergent Biosolutions Inc. EBS ██% $425M 8.1x 0.8x
Edesa Biotech, Inc. EDSA ██% $13M -1.3x 0.9x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $1M -8.2x 0.2x
Elanco Animal Health Inc ELAN ██% $13.12B 341.6x 2.0x
Eledon Pharmaceuticals, Inc. ELDN ██% $195M x 5.5x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $441M 16.7x 5.5x
Elicio Therapeutics, Inc. ELTX ██% $224M -1.9x 58.8x
Enliven Therapeutics, Inc. ELVN ██% $1.76B -13.3x 3.7x
Emmaus Life Sciences, Inc. EMMA ██% $890K x 0.2x
Enlivex Ltd. ENLV ██% $273M x 14.3x
Ensysce Biosciences, Inc. ENSC ██% $2M x 1.9x
Enanta Pharmaceuticals Inc ENTA ██% $415M -1.3x 3.3x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $3M -0.1x 0.9x
Evolus, Inc. EOLS ██% $291M -13.1x 52.8x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Equillium, Inc. EQ ██% $111M -3.2x 3.6x
Erasca, Inc. ERAS ██% $3.88B -3.1x 11.1x
Ernexa Therapeutics Inc. ERNA ██% $8M x 2.2x
Esperion Therapeutics, Inc. ESPR ██% $801M -4.2x 89.4x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $456M -66.2x 19.7x
Earth Science Tech, Inc. ETST ██% $32M 15.4x 5.6x
Evofem Biosciences, Inc. EVFM ██% $1M -0.1x 0.1x
Edgewise Therapeutics, Inc. EWTX ██% $3.19B -19.7x 5.7x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $106M 26.6x 1.9x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $22M x 3.6x
Forte Biosciences, Inc. FBRX ██% $378M -11.5x 4.5x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $321M -3.3x 2867.5x
Amicus Therapeutics, Inc. FOLD ██% $4.46B -8.5x 16.3x
Fulcrum Therapeutics, Inc. FULC ██% $598M -36.1x 1.7x
Galectin Therapeutics Inc GALT ██% $192M -2.4x 215.2x
Gain Therapeutics, Inc. GANX ██% $99M -1.4x 16.7x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $230K x x
Geron Corp GERN ██% $1.30B -11.9x 5.2x
Gh Research Plc GHRS ██% $993M x x
Galmed Pharmaceuticals Ltd. GLMD ██% $4M x 0.2x
Galapagos Nv GLPG ██% $2.22B x x
Greenwich Lifesciences, Inc. GLSI ██% $382M -17.2x 175.0x
Galecto, Inc. GLTO ██% $1.78B -2.5x 222.5x
Genelux Corp GNLX ██% $133M -2.8x 7.2x
Genprex, Inc. GNPX ██% $5M -3.2x 5.9x
Gossamer Bio, Inc. GOSS ██% $98M -3.2x 3.3x
Geovax Labs, Inc. GOVX ██% $3M x 0.6x
Structure Therapeutics Inc. GPCR ██% $4.45B -44.0x 2.9x
Grace Therapeutics, Inc. GRCE ██% $66M -3.9x 1.0x
Gri Bio, Inc. GRI ██% $4M -0.1x 0.6x
Galera Therapeutics, Inc. GRTX ██% $4M -0.3x 0.6x
Gsk Plc GSK ██% $118.65B x x
Gt Biopharma, Inc. GTBP ██% $13M x 4.3x
Gyre Therapeutics, Inc. GYRE ██% $749M 63.5x 7.4x
Hutchmed (China) Ltd HCM ██% $2.59B x 2.1x
Hcw Biologics Inc. HCWB ██% $2M x 0.2x
Hepion Pharmaceuticals, Inc. HEPA ██% $460K -0.1x 0.1x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $13M -1.0x 0.4x
Hoth Therapeutics, Inc. HOTH ██% $15M -0.5x 1.9x
Werewolf Therapeutics, Inc. HOWL ██% $28M -1.3x 1.0x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.63B 10.3x 1.9x
Heron Therapeutics, Inc. /De/ HRTX ██% $224M -6.4x 15.6x
Hst Global, Inc. HSTC ██% $35M x 28.3x
Tuhura Biosciences, Inc./Nv HURA ██% $86M x 5.1x
Ibio, Inc. IBIO ██% $97M -0.4x 1.7x
Impact Biomedical Inc. IBO ██% $46M x 11.8x
Ideaya Biosciences, Inc. IDYA ██% $2.83B -12.2x 2.8x
Inflarx N.V. IFRX ██% $63M x x
Igc Pharma, Inc. IGC ██% $26M -4.6x 3.2x
Immutep Ltd IMMP ██% $411M x x
Immix Biopharma, Inc. IMMX ██% $427M x 32.3x
Immunome Inc. IMNM ██% $2.41B -2.4x 9.1x
Imunon, Inc. IMNN ██% $11M -0.5x 2.6x
Immuron Ltd IMRN ██% $7M x x
Immuneering Corp IMRX ██% $322M -0.8x 1.4x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $123M -0.8x 11.7x
Integrated Biopharma Inc INBP ██% $9M 14.8x 0.5x
Indaptus Therapeutics, Inc. INDP ██% $5M -0.6x 1.0x
Indivior Pharmaceuticals, Inc. INDV ██% $4.09B 19.5x x
Inmed Pharmaceuticals Inc. INM ██% $2M -51.8x 0.3x
Inovio Pharmaceuticals, Inc. INO ██% $124M -0.6x 4.4x
Insmed Inc INSM ██% $31.99B -14.0x 43.3x
Inhibitor Therapeutics, Inc. INTI ██% $14M x 3998.2x
Innoviva, Inc. INVA ██% $1.71B 6.3x 1.5x
Io Biotech, Inc. IOBT ██% $24M -0.7x 26.7x
Ionis Pharmaceuticals Inc IONS ██% $13.25B -14.6x 27.1x
Opus Genetics, Inc. IRD ██% $268M -2.0x 45.0x
Disc Medicine, Inc. IRON ██% $2.52B -18.4x 3.4x
Ironwood Pharmaceuticals Inc IRWD ██% $558M 23.2x 0.8x
International Stem Cell Corp ISCO ██% $1M x 0.4x
Iterum Therapeutics Plc ITRM ██% $14M -0.8x 4.1x
Inventiva S.A. IVA ██% $1.42B x x
Incannex Healthcare Inc. IXHL ██% $51M x 0.7x
Jaguar Health, Inc. JAGX ██% $4M -0.2x 0.7x
Janux Therapeutics, Inc. JANX ██% $824M -63.7x 0.8x
Jazz Pharmaceuticals Plc JAZZ ██% $11.67B 14.3x 2.7x
Jade Biosciences, Inc. JBIO ██% $731M x 4.1x
Johnson & Johnson JNJ ██% $590.22B 22.0x 7.5x
Jupiter Neurosciences, Inc. JUNS ██% $18M x 316.6x
Kala Bio, Inc. KALA ██% $346M -0.5x 60.7x
Kalvista Pharmaceuticals, Inc. KALV ██% $797M -2.6x 46.9x
Kairos Pharma, Ltd. KAPA ██% $13M x 1.7x
Kaya Holdings, Inc. KAYS ██% $26M x x
Kamada Ltd KMDA ██% $500M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $3.30B 56.0x 5.8x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $173M -0.6x 3.4x
Keros Therapeutics, Inc. KROS ██% $432M 6.7x 0.6x
Korro Bio, Inc. KRRO ██% $114M -7.9x 1.6x
Pasithea Therapeutics Corp. KTTA ██% $20M -73.5x 1.7x
Kura Oncology, Inc. KURA ██% $760M -4.5x 3.1x
Kezar Life Sciences, Inc. KZR ██% $49M -3.2x 0.6x
Legend Biotech Corp LEGN ██% $3.51B x x
Lexaria Bioscience Corp. LEXX ██% $17M -29.3x 3.5x
Lifecore Biomedical, Inc. \De\ LFCR ██% $270M x 201.9x
Lifevantage Corp LFVN ██% $59M 7.6x 1.8x
Ligand Pharmaceuticals Inc LGND ██% $3.76B 77.4x 4.0x
Longeveron Inc. LGVN ██% $12M -0.5x 1.2x
Lianbio LIANY ██% $10M x 0.1x
Lftd Partners Inc. LIFD ██% $4M 56.1x 0.1x
Lipella Pharmaceuticals Inc. LIPO ██% $740K -3.3x 0.5x
Lixte Biotechnology Holdings, Inc. LIXT ██% $26M -0.9x 5.4x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Eli Lilly & Co LLY ██% $943.95B 45.7x 35.6x
Lipocine Inc. LPCN ██% $51M -2.6x 3.6x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $2.69B -7.2x 122.1x
Larimar Therapeutics, Inc. LRMR ██% $454M -0.8x 3.3x
Lisata Therapeutics, Inc. LSTA ██% $40M -1.0x 2.3x
Lantern Pharma Inc. LTRN ██% $37M -2.4x 3.8x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $614M -1.2x 5.1x
Lyell Immunopharma, Inc. LYEL ██% $463M -1.1x 1.4x
Maia Biotechnology, Inc. MAIA ██% $78M -1.4x 1868.5x
Mustang Bio, Inc. MBIO ██% $7M -0.1x 0.8x
Moleculin Biotech, Inc. MBRX ██% $7M -2.3x 175.2x
Mbx Biosciences, Inc. MBX ██% $1.46B x 3.8x
Seres Therapeutics, Inc. MCRB ██% $77M 14.2x 1.8x
Medicus Pharma Ltd. MDCX ██% $38M x x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $10.18B -5.7x 16.9x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $126M -2.1x 1.9x
Mira Pharmaceuticals, Inc. MIRA ██% $53M -1.6x 7.0x
Mirum Pharmaceuticals, Inc. MIRM ██% $5.53B -20.0x 17.6x
Milestone Pharmaceuticals Inc. MIST ██% $148M -2.0x 7.2x
Moonlake Immunotherapeutics MLTX ██% $1.13B -50.8x 3.7x
Mineralys Therapeutics, Inc. MLYS ██% $2.21B -4.5x 3.8x
Mannkind Corp MNKD ██% $1.01B 172.2x 57.6x
Medicinova Inc MNOV ██% $71M -7.1x 1.6x
Monopar Therapeutics MNPR ██% $365M -3.0x 2.6x
Mereo Biopharma Group Plc MREO ██% $59M x 1.3x
Merck & Co., Inc. MRK ██% $310.07B 17.0x 5.9x
Marker Therapeutics, Inc. MRKR ██% $25M -0.6x 1.3x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.30B -5.6x 6.1x
Matinas Biopharma Holdings, Inc. MTNB ██% $4M -1.7x 0.6x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $5M -0.5x 0.8x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $4.06B x 5.9x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $486M 32.2x 3.0x
Novabay Pharmaceuticals, Inc. NBY ██% $38M 8.4x 33.9x
Nucana Plc NCNA ██% $9M x x
Minerva Neurosciences, Inc. NERV ██% $270M -0.8x 33.9x
Neuphoria Therapeutics Inc. NEUP ██% $24M x 0.8x
Neurogene Inc. NGNE ██% $347M -7.3x 1.3x
Nika Pharmaceuticals, Inc NIKA ██% $786M x 192879.0x
Nektar Therapeutics NKTR ██% $1.93B -1.2x 22.7x
Nkarta, Inc. NKTX ██% $200M -1.3x 0.6x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $22M -2.1x 2.0x
Nurix Therapeutics, Inc. NRIX ██% $1.63B -7.4x 3.0x
Neurosense Therapeutics Ltd. NRSN ██% $30M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $51M -0.6x 7.0x
Neonc Technologies Holdings, Inc. NTHI ██% $245M x x
Nuvation Bio Inc. NUVB ██% $2.00B -1.2x 6.1x
Nuvalent, Inc. NUVL ██% $7.41B -30.9x 5.9x
Nuvectis Pharma, Inc. NVCT ██% $228M -3.9x 12.4x
Novartis Ag NVS ██% $321.75B x x
Northwest Biotherapeutics Inc NWBO ██% $349M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $45M -0.5x 1.9x
Ocean Biomedical, Inc. OCEA ██% $90K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $1.93B -8.2x 3.0x
Oragenics Inc OGEN ██% $3M -0.1x 0.4x
Organigram Global Inc. OGI ██% $192M x x
Organon & Co. OGN ██% $1.90B 10.2x 2.5x
Onkure Therapeutics, Inc. OKUR ██% $37M -6.9x 0.6x
Olema Pharmaceuticals, Inc. OLMA ██% $1.94B -4.0x 6.3x
Omeros Corp OMER ██% $844M -4.2x 41.2x
Beone Medicines Ltd. ONC ██% $40.83B 595.7x 9.9x
Onconetix, Inc. ONCO ██% $1M -0.3x 0.0x
Oncolytics Biotech Inc ONCY ██% $122M x x
Opko Health, Inc. OPK ██% $901M -3.5x 0.7x
Organogenesis Holdings Inc. ORGO ██% $511M 508.9x 2.0x
Orgenesis Inc. ORGS ██% $2M 0.9x 0.1x
Oric Pharmaceuticals, Inc. ORIC ██% $1.32B -4.2x 3.4x
Oruka Therapeutics, Inc. ORKA ██% $1.72B x 3.5x
Oramed Pharmaceuticals Inc. ORMP ██% $141M 3.2x 0.7x
Os Therapies Inc OSTX ██% $49M x 13.5x
Oncotelic Therapeutics, Inc. OTLC ██% $22M x 2.4x
Ovid Therapeutics Inc. OVID ██% $107M -2.6x 2.4x
One World Products, Inc. OWPC ██% $1M x 1.1x
Phibro Animal Health Corp PAHC ██% $2.21B 24.0x 6.7x
Prestige Consumer Healthcare Inc. PBH ██% $3.40B 18.2x 1.9x
Psyence Biomedical Ltd. PBM ██% $3M x x
Puma Biotechnology, Inc. PBYI ██% $358M 9.7x 3.1x
Pacira Biosciences, Inc. PCRX ██% $901M 128.1x 1.3x
Processa Pharmaceuticals, Inc. PCSA ██% $4M -0.5x 0.7x
Procyon Corp PCYN ██% $980K x 0.4x
Pds Biotechnology Corp PDSB ██% $35M -1.7x 3.7x
Pepgen Inc. PEPG ██% $428M -1.6x 2.6x
Pfizer Inc PFE ██% $157.13B 20.2x 1.8x
Precigen, Inc. PGEN ██% $1.48B -1.4x 35.2x
Phathom Pharmaceuticals, Inc. PHAT ██% $897M -1.6x 51.0x
Phio Pharmaceuticals Corp. PHIO ██% $12M -0.8x 1.2x
Pharvaris N.V. PHVS ██% $1.84B x x
Protokinetix, Inc. PKTX ██% $3M x 12.2x
Plandai Biotechnology, Inc. PLPL ██% $450K x 1.5x
Pliant Therapeutics, Inc. PLRX ██% $80M -4.5x 0.4x
Polomar Health Services, Inc. PMHS ██% $4M x 0.6x
Promis Neurosciences Inc. PMN ██% $34M -2.1x 3.7x
Pmv Pharmaceuticals, Inc. PMVP ██% $90M -1.6x 0.7x
Purple Biotech Ltd. PPBT ██% $5M x x
Propanc Biopharma, Inc. PPCB ██% $3M x 0.3x
Praxis Precision Medicines, Inc. PRAX ██% $8.74B -4.0x 10.0x
Prf Technologies Ltd. PRFX ██% $2M x 0.3x
Perrigo Co Plc PRGO ██% $1.82B -27.6x 0.6x
Prelude Therapeutics Inc PRLD ██% $168M -0.5x 2.9x
Prophase Labs, Inc. PRPH ██% $710K -0.5x 0.1x
Proqr Therapeutics N.V. PRQR ██% $156M x x
Prothena Corp Public Ltd Co PRTA ██% $467M -12.4x 1.7x
Ptc Therapeutics, Inc. PTCT ██% $5.56B 8.1x 3863.5x
Protagonist Therapeutics, Inc PTGX ██% $5.76B 119.5x 9.4x
Protagenic Therapeutics, Inc.\New PTIX ██% $900K -2.8x 0.9x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $300K -0.1x 0.1x
Pulmatrix, Inc. PULM ██% $11M -1.8x 2.9x
Provectus Biopharmaceuticals, Inc. PVCT ██% $20M x 5.7x
Palvella Therapeutics, Inc. PVLA ██% $1.38B x 35.7x
Pyxis Oncology, Inc. PYXS ██% $91M -1.3x 1.3x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $14M x 5.3x
Quantum Biopharma Ltd. QNTM ██% $14M x x
Q32 Bio Inc. QTTB ██% $56M -0.7x 9.9x
Uniqure N.V. QURE ██% $972M -2.8x 4.3x
Radiopharm Theranostics Ltd RADX ██% $39M x x
Rani Therapeutics Holdings, Inc. RANI ██% $163M -1.3x 81.6x
Rapport Therapeutics, Inc. RAPP ██% $1.38B x 2.7x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.18B -7.0x 238.0x
Rocket Pharmaceuticals, Inc. RCKT ██% $460M -4.8x 1.5x
Arcus Biosciences, Inc. RCUS ██% $2.55B -5.5x 4.0x
Dr Reddys Laboratories Ltd RDY ██% $11.97B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $81.76B 18.2x 2.6x
Revelation Biosciences, Inc. REVB ██% $3M -0.1x 0.4x
Rafael Holdings, Inc. RFL ██% $66M -0.9x 0.8x
Regen Biopharma Inc RGBP ██% $140K x 1.7x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $622M 5.5x 5.3x
Relmada Therapeutics, Inc. RLMD ██% $334M -0.1x 35.3x
Rallybio Corp RLYB ██% $40M -0.7x 0.6x
Retrieve Medical Holdings, Inc. RMHI ██% $60M x 793.6x
Rockwell Medical, Inc. RMTI ██% $35M -17.1x 1.0x
Avidity Biosciences, Inc. RNA ██% $11.01B -12.2x 6.5x
Cartesian Therapeutics, Inc. RNAC ██% $197M -2.1x 262.5x
Transcode Therapeutics, Inc. RNAZ ██% $8M -0.2x 5.6x
Rein Therapeutics, Inc. RNTX ██% $31M x 0.7x
Renovorx, Inc. RNXT ██% $32M -3.4x 4.0x
Roivant Sciences Ltd. ROIV ██% $20.54B 1.8x 4.8x
Royalty Pharma Plc RPRX ██% $26.30B 34.1x 4.1x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x 6425307.7x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $25M -4.1x 5.4x
Rhythm Pharmaceuticals, Inc. RYTM ██% $6.62B -20.3x 44.5x
Rezolute, Inc. RZLT ██% $307M -3.9x 2.4x
Cassava Sciences Inc SAVA ██% $110M -1.9x 1.4x
Sunshine Biopharma Inc. SBFM ██% $5M -0.6x 0.2x
Scienture Holdings, Inc. SCNX ██% $17M 2.9x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $20K 0.0x 0.0x
Scynexis Inc SCYX ██% $31M -2.4x 0.9x
Schrodinger, Inc. SDGR ██% $886M -7.8x 2.4x
Septerna, Inc. SEPN ██% $1.05B x 2.7x
Serina Therapeutics, Inc. SER ██% $19M 22.6x 10.8x
Sagimet Biosciences Inc. SGMT ██% $169M x 1.4x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $3M x 2.3x
Silo Pharma, Inc. SILO ██% $5M x 1.0x
Sionna Therapeutics, Inc. SION ██% $1.62B x 5.1x
Skinvisible, Inc. SKVI ██% $2M x x
Skye Bioscience, Inc. SKYE ██% $23M -0.7x 0.7x
Sol-Gel Technologies Ltd. SLGL ██% $255M x 8.0x
Silence Therapeutics Plc SLN ██% $257M x 3.5x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $2.04B 97.8x 4.5x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $839M -1.0x 18.4x
Summit Therapeutics Inc. SMMT ██% $12.86B 104.1x 19.5x
Syndax Pharmaceuticals Inc SNDX ██% $1.90B -4.1x 29.4x
Soligenix, Inc. SNGX ██% $12M -1.8x 1.5x
Sibannac, Inc. SNNC ██% $850K x 1.8x
Sensei Biotherapeutics, Inc. SNSE ██% $38M -0.4x 1.6x
Sanofi SNY ██% $117.52B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $62M -0.4x 11.6x
Scisparc Ltd. SPRC ██% $3M x x
Spero Therapeutics, Inc. SPRO ██% $122M -17.8x 4.6x
Ars Pharmaceuticals, Inc. SPRY ██% $936M -23.5x 6.3x
Sarepta Therapeutics, Inc. SRPT ██% $1.76B 162.5x 1.3x
Stoke Therapeutics, Inc. STOK ██% $2.01B 49.5x 6.5x
Shattuck Labs, Inc. STTK ██% $248M x 2.7x
Supernus Pharmaceuticals, Inc. SUPN ██% $3.13B 46.0x 3.0x
Savara Inc SVRA ██% $1.22B -8.2x 13.0x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $4M -0.6x 0.9x
Synlogic, Inc. SYBX ██% $7M 3.6x 0.7x
Spyre Therapeutics, Inc. SYRE ██% $3.36B -0.7x 4.7x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $59.23B x x
Theravance Biopharma, Inc. TBPH ██% $925M 31.5x 4.0x
Alaunos Therapeutics, Inc. TCRT ██% $7M -1.0x 2.5x
Telomir Pharmaceuticals, Inc. TELO ██% $43M x 6.2x
Tenax Therapeutics, Inc. TENX ██% $71M -14.9x 0.7x
Terns Pharmaceuticals, Inc. TERN ██% $4.58B -5.1x 16.1x
Teva Pharmaceutical Industries Ltd TEVA ██% $38.61B 27.4x 4.9x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $4.67B 10.5x 7.2x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $42M -2.3x 2.2x
Telix Pharmaceuticals Ltd TLX ██% $2.46B x x
Tango Therapeutics, Inc. TNGX ██% $1.50B -2.8x 9.4x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $186M 0.0x 0.8x
Theriva Biologics, Inc. TOVX ██% $7M -0.4x 0.1x
Tempest Therapeutics, Inc. TPST ██% $10M -0.5x 1.6x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $457M 6.9x 1.5x
Trevi Therapeutics, Inc. TRVI ██% $1.53B -6.1x 8.1x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Tvardi Therapeutics, Inc. TVRD ██% $36M x 1.3x
Travere Therapeutics, Inc. TVTX ██% $2.71B x 23.6x
Therapeuticsmd, Inc. TXMD ██% $26M 523.1x 1.0x
Tyra Biosciences, Inc. TYRA ██% $1.73B -9.5x 6.2x
Unicycive Therapeutics, Inc. UNCY ██% $144M -0.9x 3.9x
Upstream Bio, Inc. UPB ██% $415M x 1.1x
Urogen Pharma Ltd. URGN ██% $1.02B -2.5x 39.8x
United Therapeutics Corp UTHR ██% $22.14B 16.6x 3.1x
Vaccinex, Inc. VCNX ██% $3M -0.1x 0.4x
Vera Therapeutics, Inc. VERA ██% $2.62B -20.4x 4.3x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Vicapsys Life Sciences, Inc. VICP ██% $49M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $3.88B -67.5x 6.1x
Vanda Pharmaceuticals Inc. VNDA ██% $499M -16.1x 1.5x
Verrica Pharmaceuticals Inc. VRCA ██% $87M -0.5x 58.0x
Viridian Therapeutics, Inc.\De VRDN ██% $2.99B -4.5x 4.1x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $126.19B 31.9x 6.8x
Verastem, Inc. VSTM ██% $427M -6.5x 11.8x
Vistagen Therapeutics, Inc. VTGN ██% $22M -0.1x 0.4x
Viatris Inc VTRS ██% $17.57B -29.5x 0.0x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $997M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $20M -0.4x 0.5x
Whitehawk Therapeutics, Inc. WHWK ██% $155M x 1.0x
Wave Life Sciences Ltd. WVE ██% $2.61B -22.2x 5.0x
Xenetic Biosciences, Inc. XBIO ██% $6M x 1.5x
Xbiotech Inc. XBIT ██% $71M -3.5x 0.4x
Exicure, Inc. XCUR ██% $24M -1.9x 3.4x
Xenon Pharmaceuticals Inc. XENE ██% $3.46B -15.4x 6.2x
Xeris Biopharma Holdings, Inc. XERS ██% $1.01B 50.1x 262.1x
Xilio Therapeutics, Inc. XLO ██% $39M -0.5x 5.5x
Xencor Inc XNCR ██% $918M -8.4x 1.4x
Xoma Royalty Corp XOMA ██% $314M 14.5x 3.6x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $7M x x
Zenas Biopharma, Inc. ZBIO ██% $1.41B x 7.2x
Zai Lab Ltd ZLAB ██% $2.15B -95.2x 3.0x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $155M -1.4x 0.6x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $55.14B 20.6x 16.6x
Zevra Therapeutics, Inc. ZVRA ██% $511M 14.5x 3.8x
Zyversa Therapeutics, Inc. ZVSA ██% $2M x 0.3x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 5.5x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Zai Lab Ltd Stock Forecast

How accurate are Zai Lab Ltd stock predictions?

Our AI model shows a 29% Spearman correlation coefficient for ZLAB predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Zai Lab Ltd stock price forecasts?

Our analysis considers Zai Lab Ltd's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Zai Lab Ltd a good investment in 2025?

Based on our AI analysis, Zai Lab Ltd shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Zai Lab Ltd forecasts updated?

Zai Lab Ltd stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...